• 18878 Citations
  • 63 h-Index
1987 …2019
If you made any changes in Pure these will be visible here soon.

Research Output 1987 2019

2019
7 Citations (Scopus)

Adjuvant letrozole and tamoxifen alone or sequentially for postmenopausal women with hormone receptor-positive breast cancer: Long-term follow-up of the BiG 1-98 trial

BIG 1-98 Collaborative Group and the International Breast Cancer Study Group, Jan 10 2019, In : Journal of Clinical Oncology. 37, 2, p. 105-114 10 p.

Research output: Contribution to journalArticle

letrozole
Tamoxifen
Hormones
Breast Neoplasms
Disease-Free Survival
2 Citations (Scopus)

Neoadjuvant letrozole plus taselisib versus letrozole plus placebo in postmenopausal women with oestrogen receptor-positive, HER2-negative, early-stage breast cancer (LORELEI): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial

Saura, C., Hlauschek, D., Oliveira, M., Zardavas, D., Jallitsch-Halper, A., de la Peña, L., Nuciforo, P., Ballestrero, A., Dubsky, P., Lombard, J. M., Vuylsteke, P., Castaneda, C. A., Colleoni, M., Santos Borges, G., Ciruelos, E., Fornier, M., Boer, K., Bardia, A., Wilson, T. R., Stout, T. J. & 6 others, Hsu, J. Y., Shi, Y., Piccart, M., Gnant, M., Baselga, J. & de Azambuja, E., Sep 1 2019, In : The Lancet Oncology. 20, 9, p. 1226-1238 13 p.

Research output: Contribution to journalArticle

letrozole
Estrogen Receptors
Placebos
Breast Neoplasms
Odds Ratio
2018
2 Citations (Scopus)

A randomized phase II study evaluating different maintenance schedules of nab-paclitaxel in the first-line treatment of metastatic breast cancer: Final results of the IBCSG 42-12/BIG 2-12 SNAP trial

on behalf of the International Breast Cancer Study Group & Cancer Trials Ireland and SOLTI Group, Mar 1 2018, In : Annals of Oncology. 29, 3, p. 661-668 8 p., mdx821.

Research output: Contribution to journalArticle

Appointments and Schedules
Disease-Free Survival
Maintenance
docetaxel
Breast Neoplasms
3 Citations (Scopus)

Association of Somatic Driver Alterations with Prognosis in Postmenopausal, Hormone Receptor-Positive, HER2-Negative Early Breast Cancer: A Secondary Analysis of the BIG 1-98 Randomized Clinical Trial

Luen, S. J., Asher, R., Lee, C. K., Savas, P., Kammler, R., Dell'Orto, P., Biasi, O. M., Demanse, D., Jebailey, L., Dolan, S., Hackl, W., Thuerlimann, B., Viale, G., Colleoni, M., Regan, M. M. & Loi, S., Oct 1 2018, In : JAMA oncology. 4, 10, p. 1335-1343 9 p.

Research output: Contribution to journalArticle

letrozole
Breast
Randomized Controlled Trials
Hormones
Breast Neoplasms

Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial

International Breast Cancer Study Group Trial 23-01, Oct 1 2018, In : The Lancet Oncology. 19, 10, p. 1385-1393 9 p.

Research output: Contribution to journalArticle

Neoplasm Micrometastasis
Dissection
Breast Neoplasms
Disease-Free Survival
cyhalothrin
44 Citations (Scopus)

Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial

International Breast Cancer Study Group Trial 23-01, Oct 1 2018, In : The Lancet Oncology. 19, 10, p. 1385-1393 9 p.

Research output: Contribution to journalArticle

Neoplasm Micrometastasis
Dissection
Breast Neoplasms
Disease-Free Survival
cyhalothrin
21 Citations (Scopus)

Clinical considerations of the role of palbociclib in the management of advanced breast cancer patients with and without visceral metastases

Turner, N. C., Finn, R. S., Martin, M., Im, S. A., DeMichele, A., Ettl, J., Diéras, V., Moulder, S., Lipatov, O., Colleoni, M., Cristofanilli, M., Lu, D. R., Mori, A., Giorgetti, C., Iyer, S., Huang Bartlett, C. & Gelmon, K. A., Mar 1 2018, In : Annals of Oncology. 29, 3, p. 669-680 12 p., mdx821.

Research output: Contribution to journalArticle

letrozole
Breast Neoplasms
Neoplasm Metastasis
Placebos
Therapeutics
28 Citations (Scopus)

Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial

on behalf of the SOLE Investigators, Jan 1 2018, In : The Lancet Oncology. 19, 1, p. 127-138 12 p.

Research output: Contribution to journalArticle

letrozole
Breast Neoplasms
Disease-Free Survival
Therapeutics

Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial

Colleoni, M., Luo, W., Karlsson, P., Chirgwin, J., Aebi, S., Jerusalem, G., Neven, P., Hitre, E., Graas, M. P., Simoncini, E., Kamby, C., Thompson, A., Loibl, S., Gavilá, J., Kuroi, K., Marth, C., Müller, B., O'Reilly, S., Di Lauro, V., Gombos, A. & 31 others, Ruhstaller, T., Burstein, H., Ribi, K., Bernhard, J., Viale, G., Maibach, R., Rabaglio-Poretti, M., Gelber, R. D., Coates, A. S., Di Leo, A., Regan, M. M., Goldhirsch, A., Vandebroek, A., Berliere, M., Mitine, C., Vuylsteke, P., Borms, M., D'Hondt, R., Glorieux, P., Mebis, J., Verhoeven, D., Coibion, M., Forget, F., Duck, L., Verhoeven, D., Wyendaele, W., Barbeaux, A., Salmon, J. P., Bernardo, A., Amadori, D. & on behalf of the SOLE Investigators, Jan 1 2018, In : The Lancet Oncology. 19, 1, p. 127-138 12 p.

Research output: Contribution to journalArticle

letrozole
Breast Neoplasms
Disease-Free Survival
Therapeutics
18 Citations (Scopus)

Integration of clinical variables for the prediction of late distant recurrence in patients with estrogen receptor-positive breast cancer treated with 5 years of endocrine therapy: CTS5

Dowsett, M., Sestak, I., Regan, M. M., Dodson, A., Viale, G., Thurlimann, B., Colleoni, M. & Cuzick, J., Jul 1 2018, In : Journal of Clinical Oncology. 36, 19, p. 1941-1948 8 p.

Research output: Contribution to journalArticle

Estrogen Receptors
Breast Neoplasms
Recurrence
Tamoxifen
Therapeutics
Breast Neoplasms
Lobular Carcinoma
Gastrointestinal Tract
Neoplasm Metastasis
Ductal Carcinoma
4 Citations (Scopus)
Triple Negative Breast Neoplasms
Drug Therapy
Cyclophosphamide
Hand-Foot Syndrome
Safety
1 Citation (Scopus)

Mutational analysis of triple-negative breast cancers within the International Breast Cancer Study Group (IBCSG) Trial 22-00

Munzone, E., Gray, K. P., Fumagalli, C., Guerini-Rocco, E., Láng, I., Ruhstaller, T., Gianni, L., Kammler, R., Viale, G., Di Leo, A., Coates, A. S., Gelber, R. D., Regan, M. M., Goldhirsch, A., Barberis, M. & Colleoni, M., Jul 1 2018, In : Breast Cancer Research and Treatment. 170, 2, p. 351-360 10 p.

Research output: Contribution to journalArticle

Triple Negative Breast Neoplasms
Breast Neoplasms
Mutation
Recurrence
Genes

Neoadjuvant treatment with trastuzumab and pertuzumab plus palbociclib and fulvestrant in HER2-positive, ER-positive breast cancer (NA-PHER2): an exploratory, open-label, phase 2 study

Gianni, L., Bisagni, G., Colleoni, M., Del Mastro, L., Zamagni, C., Mansutti, M., Zambetti, M., Frassoldati, A., De Fato, R., Valagussa, P. & Viale, G., Feb 2018, In : The Lancet. Oncology. 19, 2, p. 249-256 8 p.

Research output: Contribution to journalArticle

Neoadjuvant Therapy
Breast Neoplasms
palbociclib
fulvestrant
pertuzumab
45 Citations (Scopus)

Neoadjuvant treatment with trastuzumab and pertuzumab plus palbociclib and fulvestrant in HER2-positive, ER-positive breast cancer (NA-PHER2): an exploratory, open-label, phase 2 study

Gianni, L., Bisagni, G., Colleoni, M., Del Mastro, L., Zamagni, C., Mansutti, M., Zambetti, M., Frassoldati, A., De Fato, R., Valagussa, P. & Viale, G., Feb 1 2018, In : The Lancet Oncology. 19, 2, p. 249-256 8 p.

Research output: Contribution to journalArticle

Neoadjuvant Therapy
Breast Neoplasms
palbociclib
fulvestrant
pertuzumab

Neoadjuvant treatment with trastuzumab and pertuzumab plus palbociclib and fulvestrant in HER2-positive, ER-positive breast cancer (NA-PHER2): an exploratory, open-label, phase 2 study

Gianni, L., Bisagni, G., Colleoni, M., Del Mastro, L., Zamagni, C., Mansutti, M., Zambetti, M., Frassoldati, A., De Fato, R., Valagussa, P. & Viale, G., 2018, In : The Lancet Oncology. 19, 2, p. 249-256 8 p.

Research output: Contribution to journalArticle

Neoadjuvant Therapy
Breast Neoplasms
Safety
palbociclib
fulvestrant
1 Citation (Scopus)
Carcinoma, Intraductal, Noninfiltrating
Breast
Cohort Studies
Breast Neoplasms
Mastectomy
1 Citation (Scopus)
Breast Neoplasms
Tamoxifen
Therapeutics
Recurrence
Aromatase Inhibitors

Overall Survival with Palbociclib and Fulvestrant in Advanced Breast Cancer

Turner, N. C., Slamon, D. J., Ro, J., Bondarenko, I., Im, S-A., Masuda, N., Colleoni, M., DeMichele, A., Loi, S., Verma, S., Iwata, H., Harbeck, N., Loibl, S., André, F., Puyana Theall, K., Huang, X., Giorgetti, C., Huang Bartlett, C. & Cristofanilli, M., Nov 15 2018, In : The New England journal of medicine. 379, 20, p. 1926-1936 11 p.

Research output: Contribution to journalArticle

Breast Neoplasms
Survival
Confidence Intervals
Placebos
Cyclin-Dependent Kinase 6

Predictors of prolonged benefit from palbociclib plus fulvestrant in women with endocrine-resistant hormone receptor–positive/human epidermal growth factor receptor 2–negative metastatic breast cancer in PALOMA-3

Cristofanilli, M., DeMichele, A., Giorgetti, C., Turner, N. C., Slamon, D. J., Im, S-A., Masuda, N., Verma, S., Loi, S., Colleoni, M., Theall, K. P., Huang, X., Liu, Y. & Bartlett, C. H., 2018, In : European journal of cancer. 104, p. 21-31 11 p.

Research output: Contribution to journalArticle

Epidermal Growth Factor Receptor
Hormones
Breast Neoplasms
Placebos
Appointments and Schedules
1 Citation (Scopus)

Reply to 'the St Gallen international expert consensus on the primary therapy of early breast cancer 2017: Te point of view of an international panel of experts in radiation oncology' by Kirova et al.

Dubsky, P., Curigliano, G., Burstein, H. J., Winer, E. P., Gnant, M., Loibl, S., Colleoni, M., Regan, M. M., Piccart-Gebhart, M., Senn, H. J., Thrlimann, B., André, F., Baselga, J., Bergh, J., Bonnefoi, H., Brucker, S. Y., Cardoso, F., Carey, L., Ciruelos, E., Cuzick, J. & 31 others, Denkert, C., Di Leo, A., Ejlertsen, B., Francis, P., Galimberti, V., Garber, J., Gulluoglu, B., Goodwin, P., Harbeck, N., Hayes, D. F., Huang, C. S., Huober, J., Khaled, H., Jassem, J., Jiang, Z., Karlsson, P., Morrow, M., Orecchia, R., Osborne, K. C., Pagani, O., Partridge, A. H., Pritchard, K., Ro, J., Rutgers, E. J. T., Sedlmayer, F., Semiglazov, V., Shao, Z., Smith, I., Toi, M., Viale, G. & on behalf of the Panel Members of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2017, Jan 1 2018, In : Annals of Oncology. 29, 1, p. 281-282 2 p., mdx543.

Research output: Contribution to journalLetter

Ribociclib plus endocrine therapy for premenopausal women with hormone-receptor-positive, advanced breast cancer (MONALEESA-7): a randomised phase 3 trial

Tripathy, D., Im, S-A., Colleoni, M., Franke, F., Bardia, A., Harbeck, N., Hurvitz, S. A., Chow, L., Sohn, J., Lee, K. S., Campos-Gomez, S., Villanueva Vazquez, R., Jung, K. H., Babu, K. G., Wheatley-Price, P., De Laurentiis, M., Im, Y-H., Kuemmel, S., El-Saghir, N., Liu, M-C. & 6 others, Carlson, G., Hughes, G., Diaz-Padilla, I., Germa, C., Hirawat, S. & Lu, Y-S., Jul 2018, In : The Lancet. Oncology. 19, 7, p. 904-915 12 p.

Research output: Contribution to journalArticle

Hormones
Breast Neoplasms
letrozole
Placebos
Therapeutics

Tailoring adjuvant endocrine therapy for premenopausal breast cancer

Francis, P. A., Pagani, O., Fleming, G. F., Walley, B. A., Colleoni, M., Láng, I., Gómez, H. L., Tondini, C., Ciruelos, E., Burstein, H. J., Bonnefoi, H. R., Bellet, M., Martino, S., Geyer, C. E., Goetz, M. P., Stearns, V., Pinotti, G., Puglisi, F., Spazzapan, S., Climent, M. A. & 16 others, Pavesi, L., Ruhstaller, T., Davidson, N. E., Coleman, R., Debled, M., Buchholz, S., Ingle, J. N., Winer, E. P., Maibach, R., Rabaglio-Poretti, M., Ruepp, B., Di Leo, A., Coates, A. S., Gelber, R. D., Goldhirsch, A. & Regan, M. M., Jul 12 2018, In : New England Journal of Medicine. 379, 2, p. 122-137 16 p.

Research output: Contribution to journalArticle

exemestane
Tamoxifen
Breast Neoplasms
Therapeutics
Recurrence
75 Citations (Scopus)

Tailoring adjuvant endocrine therapy for premenopausal breast cancer

Francis, P. A., Pagani, O., Fleming, G. F., Walley, B. A., Colleoni, M., Láng, I., Gómez, H. L., Tondini, C., Ciruelos, E., Burstein, H. J., Bonnefoi, H. R., Bellet, M., Martino, S., Geyer, C. E., Goetz, M. P., Stearns, V., Pinotti, G., Puglisi, F., Spazzapan, S., Climent, M. A. & 16 others, Pavesi, L., Ruhstaller, T., Davidson, N. E., Coleman, R., Debled, M., Buchholz, S., Ingle, J. N., Winer, E. P., Maibach, R., Rabaglio-Poretti, M., Ruepp, B., Di Leo, A., Coates, A. S., Gelber, R. D., Goldhirsch, A. & Regan, M. M., Jul 12 2018, In : New England Journal of Medicine. 379, 2, p. 122-137 16 p.

Research output: Contribution to journalArticle

exemestane
Tamoxifen
Breast Neoplasms
Therapeutics
Recurrence
2 Citations (Scopus)
value added
Magnetic resonance
magnetic resonance imaging
breast neoplasms
Magnetic resonance imaging
2 Citations (Scopus)

The use of breast imaging for predicting response to neoadjuvant lapatinib, trastuzumab and their combination in HER2-positive breast cancer: Results from Neo-ALTTO

Di Cosimo, S., Campbell, C., Azim, H. A., Galli, G., Bregni, G., Curigliano, G., Criscitiello, C., Izquierdo, M., de la Pena, L., Fumagalli, D., Fein, L., Vinholes, J., Ng, W. M. J., Colleoni, M., Ferro, A., Naume, B. J., Patel, A., Huober, J., Piccart-Gebhart, M. J., Baselga, J. & 1 others, de Azambuja, E., Jan 1 2018, In : European Journal of Cancer. 89, p. 42-48 7 p.

Research output: Contribution to journalArticle

Mammary Ultrasonography
Breast
Breast Neoplasms
Mammography
Disease-Free Survival
2017
21 Citations (Scopus)

Acquired CYP19A1 amplification is an early specific mechanism of aromatase inhibitor resistance in ERα metastatic breast cancer

Magnani, L., Frigè, G., Gadaleta, R. M., Corleone, G., Fabris, S., Kempe, H., Verschure, P. J., Barozzi, I., Vircillo, V., Hong, S. P., Perone, Y., Saini, M., Trumpp, A., Viale, G., Neri, A., Ali, S., Colleoni, M. A., Pruneri, G. & Minucci, S., Mar 1 2017, In : Nature Genetics. 49, 3, p. 444-450 7 p.

Research output: Contribution to journalArticle

Aromatase Inhibitors
Estrogen Receptors
Breast Neoplasms
Aromatase
Estrogens
21 Citations (Scopus)

Acquired CYP19A1 amplification is an early specific mechanism of aromatase inhibitor resistance in ERα metastatic breast cancer

Magnani, L., Frigè, G., Gadaleta, R. M., Corleone, G., Fabris, S., Kempe, H., Verschure, P. J., Barozzi, I., Vircillo, V., Hong, S-P., Perone, Y., Saini, M., Trumpp, A., Viale, G., Neri, A., Ali, S., Colleoni, M. A., Pruneri, G. & Minucci, S., 2017, In : Nature Genetics. 49, 3, p. 444-450 7 p.

Research output: Contribution to journalArticle

32 Citations (Scopus)

Cholesterol, cholesterol-lowering medication use, and breast cancer outcome in the BIG 1-98 study

Borgquist, S., Giobbie-Hurder, A., Ahern, T. P., Garber, J. E., Colleoni, M., Láng, I., Debled, M., Ejlertsen, B., Von Moos, R., Smith, I., Coates, A. S., Goldhirsch, A., Rabaglio, M., Price, K. N., Gelber, R. D., Regan, M. M. & Thürlimann, B., Apr 10 2017, In : Journal of Clinical Oncology. 35, 11, p. 1179-1188 10 p.

Research output: Contribution to journalArticle

Breast
Cholesterol
Breast Neoplasms
letrozole
Tamoxifen
18 Citations (Scopus)

Concurrent and sequential initiation of ovarian function suppression with chemotherapy in premenopausal women with endocrine-responsive early breast cancer: An exploratory analysis of TEXT and SOFT

Regan, M. M., Walley, B. A., Francis, P. A., Fleming, G. F., Láng, I., Gómez, H. L., Colleoni, M., Tondini, C., Pinotti, G., Salim, M., Spazzapan, S., Parmar, V., Ruhstaller, T., Abdi, E. A., Gelber, R. D., Coates, A. S., Goldhirsch, A. & Pagani, O., Jan 1 2017, In : Annals of Oncology. 28, 9, p. 2225-2232 8 p.

Research output: Contribution to journalArticle

Breast Neoplasms
Drug Therapy
Triptorelin Pamoate
Adjuvant Chemotherapy
Therapeutics
18 Citations (Scopus)

Concurrent and sequential initiation of ovarian function suppression with chemotherapy in premenopausal women with endocrine-responsive early breast cancer: An exploratory analysis of TEXT and SOFT

Regan, M. M., Walley, B. A., Francis, P. A., Fleming, G. F., Láng, I., Gómez, H. L., Colleoni, M., Tondini, C., Pinotti, G., Salim, M., Spazzapan, S., Parmar, V., Ruhstaller, T., Abdi, E. A., Gelber, R. D., Coates, A. S., Goldhirsch, A. & Pagani, O., Jan 1 2017, In : Annals of Oncology. 28, 9, p. 2225-2232 8 p.

Research output: Contribution to journalArticle

Breast Neoplasms
Drug Therapy
Triptorelin Pamoate
Adjuvant Chemotherapy
Therapeutics
18 Citations (Scopus)

Concurrent and sequential initiation of ovarian function suppression with chemotherapy in premenopausal women with endocrine-responsive early breast cancer: An exploratory analysis of TEXT and SOFT

Regan, M. M., Walley, B. A., Francis, P. A., Fleming, G. F., Láng, I., Gómez, H. L., Colleoni, M., Tondini, C., Pinotti, G., Salim, M., Spazzapan, S., Parmar, V., Ruhstaller, T., Abdi, E. A., Gelber, R. D., Coates, A. S., Goldhirsch, A. & Pagani, O., 2017, In : Annals of Oncology. 28, 9, p. 2225-2232 8 p.

Research output: Contribution to journalArticle

263 Citations (Scopus)

De-escalating and escalating treatments for early-stage breast cancer: The St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017

Curigliano, G., Burstein, H. J., Winer, E. P., Gnant, M., Dubsky, P., Loibl, S., Colleoni, M., M. Regan, M., Piccart-Gebhart, M., Senn, H. J., Thürlimann, B., André, F., Baselga, J., Bergh, J., Bonnefoi, H., Brucker, S. Y., Cardoso, F., Carey, L., Ciruelos, E., Cuzick, J. & 31 others, Denkert, C., Di Leo, A., Ejlertsen, B., Francis, P., Galimberti, V., Garber, J., Gulluoglu, B., Goodwin, P., Harbeck, N., F. Hayes, D., Huang, C. S., Huober, J., Hussein, K., Jassem, J., Jiang, Z., Karlsson, P., Morrow, M., Orecchia, R., Osborne, K. C., Pagani, O., Partridge, A. H., Pritchard, K., Ro, J., Rutgers, E. J. T., Sedlmayer, F., Semiglazov, V., Shao, Z., Smith, I., Toi, M., Viale, G. & on behalf of the Panel Members of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2017, Aug 1 2017, In : Annals of Oncology. 28, 8, p. 1700-1712 13 p., mdx308.

Research output: Contribution to journalArticle

Breast Neoplasms
Neoadjuvant Therapy
Patient Preference
Neoplasms
Therapeutics
3 Citations (Scopus)
Breast Neoplasms
Lobular Carcinoma
Gastrointestinal Tract
Neoplasm Metastasis
Ductal Carcinoma
7 Citations (Scopus)

Metronomics in the neoadjuvant and adjuvant treatment of breast cancer

Munzone, E. & Colleoni, M., Aug 1 2017, In : Cancer Letters. 400, p. 259-266 8 p.

Research output: Contribution to journalShort survey

Neoadjuvant Therapy
Breast Neoplasms
Drug Therapy
Therapeutics
Triple Negative Breast Neoplasms

Reply to L. Moscetti

Colleoni, M., Gray, K. P., Gelber, R. D., Regan, M. M. & Goldhirsch, A., May 10 2017, In : Journal of Clinical Oncology. 35, 14, 1 p.

Research output: Contribution to journalLetter

34 Citations (Scopus)
Nipples
Mastectomy
Feasibility Studies
Robotics
Learning Curve
17 Citations (Scopus)
Cyclophosphamide
Breast Neoplasms
Safety
Hand-Foot Syndrome
Leukopenia
29 Citations (Scopus)

Treatment efficacy, adherence, and quality of life among women younger than 35 years in the international breast cancer study group TEXT and SOFT adjuvant endocrine therapy trials

Saha, P., Regan, M. M., Pagani, O., Francis, P. A., Walley, B. A., Ribi, K., Bernhard, J., Luo, W., Gómez, H. L., Burstein, H. J., Parmar, V., Torres, R., Stewart, J., Bellet, M., Perelló, A., Dane, F., Moreira, A., Vorobiof, D., Nottage, M., Price, K. N. & 6 others, Coates, A. S., Goldhirsch, A., Gelber, R. D., Colleoni, M., Fleming, G. F. & SOFT and TEXT Investigators and International Breast Cancer Study Group, Sep 20 2017, In : Journal of Clinical Oncology. 35, 27, p. 3113-3122 10 p.

Research output: Contribution to journalArticle

exemestane
Tamoxifen
Quality of Life
Breast Neoplasms
Therapeutics
7 Citations (Scopus)
Tumor-Infiltrating Lymphocytes
Hormones
Breast Neoplasms
Drug Therapy
Cyclophosphamide
2016
63 Citations (Scopus)

Absolute benefit of adjuvant endocrine therapies for premenopausal women with hormone receptor-positive, Human epidermal growth factor receptor 2-Negative early breast cancer: TEXT and SOFT Trials

Regan, M. M., Francis, P. A., Pagani, O., Fleming, G. F., Walley, B. A., Viale, G., Colleoni, M., Láng, I., Gómez, H. L., Tondini, C., Pinotti, G., Price, K. N., Coates, A. S., Goldhirsch, A. & Gelber, R. D., Jul 1 2016, In : Journal of Clinical Oncology. 34, 19, p. 2221-2230 10 p.

Research output: Contribution to journalArticle

exemestane
Tamoxifen
Hormones
Breast Neoplasms
Therapeutics

Adjuvant Tamoxifen Plus Ovarian Function Suppression Versus Tamoxifen Alone in Premenopausal Women With Early Breast Cancer: Patient-Reported Outcomes in the Suppression of Ovarian Function Trial

Ribi, K., Luo, W., Bernhard, J., Francis, P. A., Burstein, H. J., Ciruelos, E., Bellet, M., Pavesi, L., Lluch, A., Visini, M., Parmar, V., Tondini, C., Kerbrat, P., Perelló, A., Neven, P., Torres, R., Lombardi, D., Puglisi, F., Karlsson, P., Ruhstaller, T. & 7 others, Colleoni, M., Coates, S. G. A. S., Goldhirsch, A., Price, K. N., Gelber, R. D., Regan, M. & Fleming, G. F., May 10 2016, In : Journal of Clinical Oncology. 34, 14, p. 1601-10 10 p.

Research output: Contribution to journalArticle

Tamoxifen
Breast Neoplasms
Drug Therapy
Quality of Life
Therapeutics
101 Citations (Scopus)

Annual hazard rates of recurrence for breast cancer during 24 years of follow-up: Results from the international breast cancer study group trials I to V

Colleoni, M., Sun, Z., Price, K. N., Karlsson, P., Forbes, J. F., Thürlimann, B., Gianni, L., Castiglione, M., Gelber, R. D., Coates, A. S. & Goldhirsch, A., Mar 20 2016, In : Journal of Clinical Oncology. 34, 9, p. 927-935 9 p.

Research output: Contribution to journalArticle

Breast Neoplasms
Recurrence
Estrogen Receptors
Disease-Free Survival
Clinical Trials
60 Citations (Scopus)

Clinical validity of tumor-infiltrating lymphocytes analysis in patients with triple-negative breast cancer

Pruneri, G., Vingiani, A., Bagnardi, V., Rotmensz, N., De Rose, A., Palazzo, A., Colleoni, M. A., Goldhirsch, A. & Viale, G., Feb 1 2016, In : Annals of Oncology. 27, 2, p. 249-256 8 p., mdv571.

Research output: Contribution to journalArticle

Triple Negative Breast Neoplasms
Tumor-Infiltrating Lymphocytes
Breast Neoplasms
Disease-Free Survival
Survival
507 Citations (Scopus)

Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): Final analysis of the multicentre, double-blind, phase 3 randomised controlled trial

Cristofanilli, M., Turner, N. C., Bondarenko, I., Ro, J., Im, S. A., Masuda, N., Colleoni, M., DeMichele, A., Loi, S., Verma, S., Iwata, H., Harbeck, N., Zhang, K., Theall, K. P., Jiang, Y., Bartlett, C. H., Koehler, M. & Slamon, D., 2016, (Accepted/In press) In : The Lancet Oncology.

Research output: Contribution to journalArticle

Randomized Controlled Trials
Placebos
Hormones
Breast Neoplasms
Disease-Free Survival
33 Citations (Scopus)

Low-dose oral cyclophosphamide and methotrexate maintenance for hormone receptor-negative early breast cancer: International Breast Cancer Study Group Trial 22-00

Colleoni, M., Gray, K. P., Gelber, S., Láng, I., Thürlimann, B., Gianni, L., Abdi, E. A., Gomez, H. L., Linderholm, B. K., Puglisi, F., Tondini, C., Kralidis, E., Eniu, A., Cagossi, K., Rauch, D., Chirgwin, J., Gelber, R. D., Regan, M. M., Coates, A. S., Price, K. N. & 2 others, Viale, G. & Goldhirsch, A., Oct 1 2016, In : Journal of Clinical Oncology. 34, 28, p. 3400-3408 9 p.

Research output: Contribution to journalArticle

Methotrexate
Cyclophosphamide
Maintenance
Hormones
Breast Neoplasms
1 Citation (Scopus)

Neoadjuvant nab-paclitaxel in breast cancer: Trial results and patient care

Colleoni, M., Mar 1 2016, In : The Lancet Oncology. 17, 3, p. 265-266 2 p.

Research output: Contribution to journalArticle

25 Citations (Scopus)
Segmental Mastectomy
Mastectomy
Cohort Studies
Incidence
Breast Neoplasms